within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M02A_TopicalProductsForJointAndMuscularPain.M02AA22_Suxibuzone;

model Suxibuzone
  extends Pharmacolibrary.Drugs.ATC.M.M02AA22;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M02AA22</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Suxibuzone is a non-steroidal anti-inflammatory drug (NSAID) from the pyrazolone group, formerly used in the treatment of pain and inflammation in musculoskeletal disorders, particularly in animals. It acts as a prodrug of phenylbutazone and oxyphenbutazone. It is not commonly used or approved for human clinical applications today.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic data are available for suxibuzone; parameters estimated based on its status as a pyrazolone NSAID and as a prodrug of phenylbutazone. Estimated parameters for an oral administration in a typical adult.</p><h4>References</h4><ol><li><p>Jaraiz, V, et al., &amp; San Andres, MI (1999). Pharmacokinetics and bioequivalence of two suxibuzone oral dosage forms in horses. <i>Journal of veterinary pharmacology and therapeutics</i> 22(4) 247–254. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2885.1999.00219.x&quot;>10.1046/j.1365-2885.1999.00219.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10499236/&quot;>https://pubmed.ncbi.nlm.nih.gov/10499236</a></p></li><li><p>Yasuda, Y, et al., &amp; Kageyama, T (1982). Comparison of the absorption, excretion, and metabolism of suxibuzone and phenylbutazone in humans. <i>Journal of pharmaceutical sciences</i> 71(5) 565–572. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600710521&quot;>10.1002/jps.2600710521</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7097505/&quot;>https://pubmed.ncbi.nlm.nih.gov/7097505</a></p></li><li><p>Delbeke, FT, et al., &amp; Debackere, M (1993). The disposition of suxibuzone in the horse. <i>Journal of veterinary pharmacology and therapeutics</i> 16(3) 283–290. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.1993.tb00175.x&quot;>10.1111/j.1365-2885.1993.tb00175.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8230399/&quot;>https://pubmed.ncbi.nlm.nih.gov/8230399</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Suxibuzone;
